Home
Login Register
Biosensors   

Is Biosensors a good buy?

 Post Reply 2401-2420 of 10899
 
bishan22
    25-Apr-2012 09:42  
Contact    Quote!
Cranking up again. Not vested.  Smiley
 
 
allright
    25-Apr-2012 08:45  
Contact    Quote!


From Maybank Kim Eng
Biosensors International - Whither the price of stents (BUY, TP SGD1.67, BIG SP, Healthcare)
 
Ø   While we think that Biosensors could easily attain its 80% topline growth for FY3/12 as guided, we fear that margins are becoming increasingly vulnerable to ASP pressure where an adverse impact would likely be felt from FY3/13F onwards.
Ø   Industry sources expect Beijing’s new DES tender process to lead to a 15% price cut. Outside of China however, ASP pressures have moderated.
Ø   Even after making downward adjustments to our forecasts, we find that valuations are still attractive and the recent sell-down is overdone. Maintain BUY with SOTP-based target price of SGD1.67.
 
Click  HEREto download PDF report
 
YEAK Chee Keong, CFAyeakcheekeong@maybank-ke.com.sg(65) 6433 5730
 
 
thunderdoor
    24-Apr-2012 14:10  
Contact    Quote!
Same situation as last month if you read the backlog of this thread. Some will wait till 1.30, but if I can i will buy anywhere between 1.38-1.4 and hold till 1.54. 1.365 is not impossible but will probably have to be quick. Hold and do not waiver.
 

 
ricourean
    24-Apr-2012 14:04  
Contact    Quote!


journey to where? up or down?

I guess it  depends on when you come in and the time frame one is  looking at.
 
 
wangerism
    24-Apr-2012 14:01  
Contact    Quote!


Takin a breather before continuing its journey...

 

rutheone1905      ( Date: 24-Apr-2012 12:22) Posted:

Still no new low support yet so dont act now just let it rot.

rutheone1905      ( Date: 23-Apr-2012 11:39) Posted:

Bio drops below the critical support of 1.54 will keep dropping till new support emerge stay clear.


 
 
rutheone1905
    24-Apr-2012 12:22  
Contact    Quote!
Still no new low support yet so dont act now just let it rot.

rutheone1905      ( Date: 23-Apr-2012 11:39) Posted:

Bio drops below the critical support of 1.54 will keep dropping till new support emerge stay clear.

 

 
ricourean
    24-Apr-2012 11:54  
Contact    Quote!


Probably will not take more than 6weeks. That is because EuroPCR coming in mid May and earnings will also be announced around that time. It should start to rebounce by then.
 
 
chanting
    24-Apr-2012 11:31  
Contact    Quote!
Due to the recent massive selldown, this injure old man will need 4-12 weeks of recovery, which is a norm for a selldown counter........ from backdoor news,   BB are definately the culprit and SGX will not interfere because once they start to enquiry on the selldown, their doorstep will also start to see sparks, because they are aiming on him too....I'll give them sometime to sort things out....
 
 
wangerism
    23-Apr-2012 17:36  
Contact    Quote!


coming close to 200ma support... it should...can look to enter @ 1.385 -1.395 region...

 

stocksburntme      ( Date: 23-Apr-2012 15:19) Posted:

gonna see below 1.4 soon~~

 
 
stocksburntme
    23-Apr-2012 15:19  
Contact    Quote!
gonna see below 1.4 soon~~
 

 
rutheone1905
    23-Apr-2012 11:39  
Contact    Quote!
Bio drops below the critical support of 1.54 will keep dropping till new support emerge stay clear.
 
 
wangerism
    23-Apr-2012 11:04  
Contact    Quote!


Bio found the floor?

 
 
 
allright
    23-Apr-2012 10:52  
Contact    Quote!


Last year the announcement for the notification for the 4th qtr full   year end results was on May 10 2011 and the results was on May 26th 2011 so its NOT late this year.

Not a call to buy or sell just info to be given. Good luck bros

infancybird      ( Date: 23-Apr-2012 10:34) Posted:

We small investors are at blind spot currently, not sure not the BB is  planning and their  intention to keep price below 1.45 . For me, just wait for their full yr report which will be out soon in May. Surprisingly the release date is yet to  be made known...could the mgt be waiting to coincide with some  events or some final figures from associate companies??      This counter really test one`s nerve.         

ChillX      ( Date: 23-Apr-2012 10:09) Posted:

Hate this sort of counter... good potential, but sudden dip for no particular reason or obvious reason.


 
 
infancybird
    23-Apr-2012 10:34  
Contact    Quote!
We small investors are at blind spot currently, not sure not the BB is  planning and their  intention to keep price below 1.45 . For me, just wait for their full yr report which will be out soon in May. Surprisingly the release date is yet to  be made known...could the mgt be waiting to coincide with some  events or some final figures from associate companies??      This counter really test one`s nerve.         

ChillX      ( Date: 23-Apr-2012 10:09) Posted:

Hate this sort of counter... good potential, but sudden dip for no particular reason or obvious reason.

 
 
chanting
    23-Apr-2012 10:26  
Contact    Quote!
2 camps here : 1) suggest not to buy due to bear flag might be forming, and unfavourable TA 2)suggest to load up due to price lower and SDFA announcement + earning report.... Either way its correct.... For my opinion, if you are able to endure the drop/lost, buy a minimal sum with your spare money and wait for the rise because the SFDA news round the corner might cause this counter to rise... Just my opinion and your choice...

tanventure      ( Date: 22-Apr-2012 20:15) Posted:



Big drop last week for the stock, from S$1.58 to 1.425, about -10%,

large volumes were on Tues. and Wed,  past one year's gain has been totally

wiped out. Now it's -17% from the one year high of S$1.70

  Wonder if this is a good entry point for a long term, say, 3-5 years,

investors?

  Thanks

Tan




 

 
allright
    23-Apr-2012 10:19  
Contact    Quote!


  This was on Friday -but target price is still$1.80

0704 GMT [Dow Jones] STOCK CALL: Credit Suisse cuts Biosensors' (B20.SG) target to S$1.80 from S$2.00 after lowering FY13-14 EPS forecasts 13% and 19%. The Japan market, which contributed about 28.3% of FY12 revenue, could face more competition from multinationals' new product launches, while the government also implemented a drug-eluting-stent price cut of about 14.5%, effective April 1, it says. It adds, China DES volume growth appears to be slowing, based on FY11 results from all major local DES players, while most players expect Beijing's new DES tender process to have a 15%-20% price cut. Credit Suisse expects additional operating expenses from Biosensors' plan to develop a new manufacturing, R& D and operational headquarters in Singapore and set up a Spain subsidiary. But it keeps an Outperform call " given the high potential to diversify its product portfolio to capture growth opportunities in emerging markets, we recommend to accumulate on current share price weakness." It estimates the stock trades at only 12X FY14 EPS. The stock falls 0.7% to S$1.45. (leslie.shaffer@dowjones.com)
 
 
ChillX
    23-Apr-2012 10:09  
Contact    Quote!
Hate this sort of counter... good potential, but sudden dip for no particular reason or obvious reason.
 
 
stocksburntme
    23-Apr-2012 09:34  
Contact    Quote!
down again....pui.
 
 
gbleng
    23-Apr-2012 09:09  
Contact    Quote!
They're sooo lame!!! useless bunch of overseers.....
 
 
topdog22
    23-Apr-2012 08:10  
Contact    Quote!
Why no investigation by SGX or MAS????  Even to find out if stock manipulated???
 
Important: Please read our Terms and Conditions and Privacy Policy .